Last month, Turing Pharmaceuticals caused widespread outrage when it raised the price of the drug Daraprim from $13.50 a pill to $750. Daraprim is a critical life-saving drug that is decades old, but was only available from Turing.
The good news is that all the publicity attracted the attention of another drug company, Imprimis Pharmaceuticals. Imprimis has just announced an alternative to Daraprim, which they have priced at a much more reasonable $1 a pill.
Imprimis also said it has plans to produce more cheap alternative drugs. Their goal is to come out with more affordable versions of the 7,800 generic FDA-approved drugs.
It remains to be seen whether this is just a clever marketing ploy, or if Imprimis is really serious about creating more competition for prescription drugs. But it is a good start.